{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:50:36Z","timestamp":1793850636849,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.cca.2013.02.016","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T00:46:35Z","timestamp":1361839595000},"page":"31-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity"],"prefix":"10.1016","volume":"421","author":[{"given":"G.","family":"Brandhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Raddatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Karaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Oellerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.D.","family":"Walson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.02.016_bb0005","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2013.02.016_bb0010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.cca.2013.02.016_bb0015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1172\/JCI30587","article-title":"The fundamental basis of inflammatory bowel disease","volume":"117","author":"Strober","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.02.016_bb0020","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1995.tb03836.x","article-title":"Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)","volume":"102","author":"Duchmann","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2013.02.016_bb0025","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","article-title":"Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease","volume":"126","author":"Mow","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2013.02.016_bb0030","first-page":"123","article-title":"The diagnosis and treatment of Crohn's disease and ulcerative colitis","volume":"106","author":"Baumgart","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.cca.2013.02.016_bb0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4161\/self.1.4.13560","article-title":"Immunopathogenesis of inflammatory bowel disease","volume":"1","author":"Matricon","year":"2010","journal-title":"Self Nonself"},{"key":"10.1016\/j.cca.2013.02.016_bb0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nri2340","article-title":"The genetics and immunopathogenesis of inflammatory bowel disease","volume":"8","author":"Cho","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cca.2013.02.016_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cca.2013.02.016_bb0050","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2013.02.016_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.ftd.0000194503.85763.f5","article-title":"Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics","volume":"28","author":"Oellerich","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cca.2013.02.016_bb0060","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/FTD.0b013e3181efb3d2","article-title":"Biomarkers as a tool for management of immunosuppression in transplant patients","volume":"32","author":"Wieland","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cca.2013.02.016_bb0065","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1373\/clinchem.2010.159871","article-title":"Individually tailored immunosuppression: is there a role for biomarkers?","volume":"57","author":"Brandhorst","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.02.016_bb0070","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cca.2012.05.011","article-title":"Biomarkers in transplantation medicine: guide to the next level in immunosuppressive therapy","volume":"413","author":"Wieland","year":"2012","journal-title":"Clinica Chemica Acta"},{"key":"10.1016\/j.cca.2013.02.016_bb0075","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.tp.0000234837.02126.70","article-title":"Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay","volume":"82","author":"Kowalski","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cca.2013.02.016_bb0080","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/01.tp.0000250655.14026.5c","article-title":"Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: correlation between low T-cell responses and infection","volume":"82","author":"Thai","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cca.2013.02.016_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2013.02.016_bb0090","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2013.02.016_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2013.02.016_bb0100","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2005.081950a","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cca.2013.02.016_bb0105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1309\/23YGPB1E758ECCFP","article-title":"Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation","volume":"129","author":"Batal","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cca.2013.02.016_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management","volume":"17","author":"Kowalski","year":"2003","journal-title":"Clin Transplant"},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2013.02.016_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2036.17.s2.17.x","article-title":"Review article: Crohn's disease: monitoring disease activity","volume":"17","author":"Sostegni","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cca.2013.02.016_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1745-6215-8-17","article-title":"Outcome measurement in clinical trials for ulcerative colitis: towards standardization","volume":"8","author":"Cooney","year":"2007","journal-title":"Trials"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T03:28:54Z","timestamp":1562729334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":24,"alternative-id":["S0009898113000697"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.02.016","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}